| Literature DB >> 29959849 |
Fang Hu1, Duo Mao1, Xiaolei Cai1, Wenbo Wu1, Deling Kong2, Bin Liu1.
Abstract
Bio-orthogonal tumor labeling is more effective in delivering imaging agents or drugs to a tumor site than active targeting strategy owing to covalent ligation. However, to date, tumor-specific imaging through bio-orthogonal labeling largely relies on body clearance to differentiate target from the intrinsic probe signal owing to the lack of light-up probes for in vivo bio-orthogonal labeling. Now the first light-up probe based on a fluorogen with aggregation-induced emission for in vivo bio-orthogonal fluorescence turn-on tumor labeling is presented. The probe has low background fluorescence in aqueous media, showing negligible non-specific interaction with normal tissues. Once it reacts with azide groups introduced to tumor cells through metabolic engineering, the probe fluorescence is lightened up very quickly, enabling rapid tumor-specific imaging. The photosensitizing ability was also used to realize effective image-guided photodynamic tumor therapy.Entities:
Keywords: aggregation-induced emission; bio-orthogonal labeling; light-up probes; photodynamic therapy
Mesh:
Substances:
Year: 2018 PMID: 29959849 DOI: 10.1002/anie.201805446
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336